Regular monitoring of serum 25(OH)D levels and immune markers, including CD8+ T cell counts and function, ensures controlled vitamin D deficiency, allowing studies on its impact on EBV control, immune dysregulation and MS development. This evidence concerns the gene CD8A and myeloid sarcoma.